Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$1.01 - $17.0 $137,949 - $2.32 Million
136,584 New
136,584 $207,000
Q1 2022

May 05, 2022

SELL
$1.4 - $5.15 $473,785 - $1.74 Million
-338,418 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$4.27 - $6.97 $1.45 Million - $2.36 Million
338,418 New
338,418 $1.77 Million
Q3 2020

Nov 09, 2020

SELL
$9.98 - $18.04 $215,568 - $389,664
-21,600 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$7.49 - $15.16 $161,784 - $327,456
21,600 New
21,600 $327,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $168M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.